Letter: placebo run-in for IBS clinical trials-is it useful?

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

23 Downloads (Pure)

Original language	English
Pages (from-to)	1237-1238
Number of pages	2
Journal	Alimentary Pharmacology & Therapeutics
Volume	52
Issue number	7
DOIs	https://doi.org/10.1111/apt.16027
Publication status	Published - Oct 2020

Keywords

@article{dab342d9d1164cd4a932cd2a16d81bd7,

title = "Letter: placebo run-in for IBS clinical trials-is it useful?",

keywords = "OTILONIUM BROMIDE, DOUBLE-BLIND",

author = "Bosman, {Michelle H. M. A.} and Daniel Keszthelyi",

year = "2020",

month = oct,

doi = "10.1111/apt.16027",

language = "English",

volume = "52",

pages = "1237--1238",

journal = "Alimentary Pharmacology & Therapeutics",

issn = "0269-2813",

publisher = "Wiley",

number = "7",

}

TY - JOUR

T1 - Letter

T2 - placebo run-in for IBS clinical trials-is it useful?

AU - Bosman, Michelle H. M. A.

AU - Keszthelyi, Daniel

PY - 2020/10

Y1 - 2020/10

KW - OTILONIUM BROMIDE

KW - DOUBLE-BLIND

U2 - 10.1111/apt.16027

DO - 10.1111/apt.16027

M3 - Comment/Letter to the editor

C2 - 33016542

SN - 0269-2813

VL - 52

SP - 1237

EP - 1238

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 7

ER -